Impact of dexamethasone in severe COVID-19-induced acute kidney injury: a multicenter cohort study

Abstract Background Acute kidney injury (AKI) in intensive care unit (ICU) patients with severe COVID-19 is common (> 50%). A specific inflammatory process has been suggested in the pathogenesis of AKI, which could be improved by dexamethasone (DXM). In a small monocenter study (n = 100 patients), w...

Descripció completa

Dades bibliogràfiques

Autors principals:	Sébastien Rubin, Arthur Orieux, Mathilde Prezelin-Reydit, Antoine Garric, Yoann Picard, Nouchan Mellati, Lisa Le Gall, Antoine Dewitte, Renaud Prevel, Didier Gruson, Guillaume Louis, Alexandre Boyer, for the Groupe Recherche Rein Réanimation (G3R)
Format:	Artigo
Idioma:	Inglês
Publicat:	Elsevier 2024-02-01
Col·lecció:	Annals of Intensive Care
Matèries:	Acute kidney injury Intensive care unit COVID-19 Dexamethasone
Accés en línia:	https://doi.org/10.1186/s13613-024-01258-6
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!